LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) — key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2024)

$128.9M

Net Income/Loss (FY2024)

-$38.7M

Total Assets (FY2024)

$239.3M

Total Equity (FY2024)

$1.3M

Cash Flows from Operating Activities (FY2024)

-$206.0K

Source: LIFECORE BIOMEDICAL, INC. \DE\ 10-K filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.